763038001: Enasidenib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Dehydrogenase inhibitor\Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action (substance)\Enasidenib

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Enasidenib

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Aminopyridine\Enasidenib

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Aminopyridine\Enasidenib
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Aminopyridine\Enasidenib

\Substance categorized functionally\Industrial and household substance\...

\Agrochemical\Agrochemical biocide\Pesticide\Fungicide\Aminopyridine\Enasidenib

\Industrial product\Pesticide\Fungicide\Aminopyridine\Enasidenib

\Biocide\Agrochemical biocide\Pesticide\Fungicide\Aminopyridine\Enasidenib

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3637621017 Enasidenib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3637622012 Enasidenib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Enasidenib	Is a	Aminopyridine	true	Inferred relationship	Some
Enasidenib	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Isocitrate dehydrogenase-2 inhibitor (disposition)	true	Inferred relationship	Some
Enasidenib	Is a	Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action (substance)	true	Inferred relationship	Some
Enasidenib	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Enasidenib	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Enasidenib mesilate (substance)	Is a	False	Enasidenib	Inferred relationship	Some
Product containing enasidenib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Enasidenib	Inferred relationship	Some	1
Product containing enasidenib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Enasidenib	Inferred relationship	Some	1
Enasidenib mesilate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Enasidenib	Inferred relationship	Some
Enasidenib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Enasidenib	Inferred relationship	Some	1
Product containing only enasidenib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Enasidenib	Inferred relationship	Some	1

Reference Sets